NAT2 slow acetylation and GSTM1 null genotypes increase bladder cancer risk: results from the Spanish Bladder Cancer Study and meta-analyses

Background: Many associations between common genetic polymorphisms and complex diseases have not been replicated. One of the few exceptions may be the association between NAT2 slow acetylation, GSTM1 null genotype and bladder cancer risk. However, current evidence is based on meta-analyses of relati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: García-Closas, Montserrat, Malats, Núria, Silverman, Debra, Dosemeci, Mustafa, Kogevinas, Manolis, Hein, David W., Tardón, Adonina, Serra, Consol, Carrato, Alfredo, García-Closas, Reina, Lloreta, Josep, Castaño-Vinyals, Gemma, Yeager, Meredith, Welch, Robert, Chanock, Stephen, Chatterjee, Nilanjan, Wacholder, Sholom, Samanic, Claudine, Torà, Montserrat, Fernández, Francisco, Real, Francisco X., Rothman, Nathaniel
Format: Artigo
Jezik:Inglês
Izdano: 2005
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1459966/
https://ncbi.nlm.nih.gov/pubmed/16112301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(05)67137-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items